MYOC and open-angle glaucoma: Specifically, by delivering stem cells into the eyes of a mutant myocilin mouse model of POAG and observing the effects on IOP and AH dynamics for an extended period of time, we wished to evaluate the potential of this treatment for eventual clinical translation (Coulon et al., 2022).